Outcome of Board Meeting

02" September, 2026 The Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited Ground Floor, P. J. Tower, Exchange Plaza, 5" Floor Plot No. C/1, Dalal Street, G. Block Bandra-Kurla Complex, Mumbai-400001 Bandra (E), Mumbai - 400 051 Serip Code: 524632 NSE Symbol: SHUKRAPHAR Scrip Code: 524632 Dear Sir/Madam, Sub.: Outcome of Board Meeting dated September 02, 2026 — Allotment of 11,73,000 fully paid- up Equity Shares of Rupees 1/~ each upon conversion of warrants into Equity shares, on Preferential Basis Ref: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") In furtherance to our letter dated January 28, 2026, and pursuant to Regulation 30 read with Schedule I of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that the Board of Directors of the company in its Meeting held today i.e. Wednesday, September 02, 2026, has approved allotment of 11,73,000 fully paid up equity shares of the face value of Re.1/- each to Navkar Surgical Gujarat Limited, warrant holders (Promoter), pursuant to exercise of their right to convert share warrants (the “Warrants”) into equity shares and the details of the said warrants are given below: Sr. | Name of the | Category No. of | No. of | No. of | No. of No. | Allottee (Promoter/ | warrants | warrants warrants warrants Non - allotted already applied for | Pending for Promoter) converted | conversion conversion 1 | Navkar Promoter, 11,73,000 | 0 11,73,000 0 Surgical Body Gujarat Corporate Limited Total 11,73,000 | 0 11,73,000 0 The allotment has been made for cash, upon receipt of the remaining exercise price of Rs.26.67/- per share warrant (being an amount equivalent to 75% of the warrant exercise price of Rs.35.56/- per warrant), aggregating to Rs.3,12,83,910/- (Rupees Three Crore Twelve Lakh Eighty-Three Thousand Nine Hundred Ten Only). The equity shares so allotted on the exercise of warrants on a preferential basis shall rank pari passu with the existing equity shares of the Company in all respects. CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com .C'énsequen o the aforesaid allotment, the paid-up equity capital of the Co‘n:lpany has increased from Rs.43,96.14,440/- consisting of 43,96,14,440 Equity Shares of Re.l/- each to Rs.44,07,87,440/- consisting of 44,07,87,440 Equity Shares of Re.1/- each. After considering the aforementioned allotment of 11,73,000 equity shares pursuant to the conversion of fully convertible warrants, the reconciliation of outstanding warrants as allotted on January 28, 2026, would remain as below: Particulars No. of Warrants Total Warrants allotted on January 28, 2026 46,43,000 Less: Warrants converted into equity shares till September 02, 2026 29,08,000 Total Outstanding Warrants 17,35,000 It may be please noted that 17,35,000 total warrants are outstanding for conversion, and these warrant holders are entitled to get their warrants converted into an equal number of Equity Shares of the Company by paying the remaining 75% i.e., Rs.26.67/- per warrant within 18 months from the date of warrant allotment. Details as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, which was further updated on January 30, 2026 under tracking reference HO/49/14/14(7)2025- CFD-POD2/1/3762/2026, is enclosed herewith as Annexure A. The Board Meeting commenced at 06.00 p.m. and concluded at 06.30 p.m. Kindly take the same on your records. Thanking you, Yours faithfully, Shivkant Dhakad Company Secretary Membership Number: A80894 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com Annexure- A SN_| Particulars Details 1 Types of Securities proposed to | Equity Shares are allotted on the conversion of fully paid Warrants. be issued 2 | Types of Issuances Preferential allotment on a private placement basis in accordance with the provisions of the Companies Act, 2013 and the rules made thereunder and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“ICDR Regulations”) and other applicable laws. (Conversion of Warrants into Equity Shares). 3 | Total number of securities | Allotment of 11,73,000 (Eleven Lakhs Seventy Three Thousand) Equity Shares of proposed to be issued or the total | the face value of Re.1/- each upon conversion of equal number of warrants at an amount for which the securities | issue price of Rs.35.56/- each (Thirty-Five Rupees and Fifty Six Paisa Only) upon will be issued (Approximately) | receipt of the balance amount at the rate of Rs.26.67/- (Twenty Six Rupees Sixty Seven Paisa Only) per warrant (as “Warrant Exercise Price”) aggregating to Rs.3,12,83,910/- (Rupees Three Crore Twelve Lakh Eighty-Three Thousand Nine Hundred Ten Only). 4 | Name oft he Investors As per Schedule -1 5 | Post allotment of securities- The equity shares are proposed to be allotted to Public (Non- Promoter). Details of outcome of the subscription the shareholding of Investors in the Company, prior to and after the proposed Preferential Issue, are as under: As per Schedule - 1 6 | Issue Price Warrants had been allotted on January 28, 2026, carrying a right to subscribe to 1 Equity Share per warrant on receipt of the amount at Rs.8.89/- per warrant (25% of the issue price per warrant). Now, 11,73,000 Equity Shares have been allotted on receipt of balance amount at the rate of Rs.26.67/- per warrant (being 75% of the issue price per warrant). 7 | Number of Investors 1 8 | In case of convertibles — Not Applicable Intimation on conversion of securities or on lapse of the tenure oft he instrument; 9 | Any cancellation or termination | Not Applicable of proposal for issuance of securities including reasons thereof. Schedule -1 Sr. No. | Name of Pre issue shareholding Post issue shareholding Shareholder No. of equity Percentage No. of shares Percentage of shares held Post capital total holding (post diluted) 1 Navkar Surgical 5,16,00,000 11.78 5,27,73,000 11.93 Gujarat Limited Total 5,16,00,000 11.78 5,27,73,000 11.93 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com